Modern Biosciences Ltd.
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
Phase 1
Recruiting
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2024-04-23
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT06379958
- Locations
- π¬π§
Celerion, Belfast, United Kingdom
A Study to Investigate Leramistat in Patients With IPF
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT05951296
- Locations
- πΊπΈ
Reliant Medical Research, Miami, Florida, United States
πΊπΈSouthern Medical Research, LLC, Macon, Georgia, United States
πΊπΈGenHarp Clinical Solutions, Chicago, Illinois, United States
Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA
Phase 2
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: PlaceboDrug: MBS2320 5 mgDrug: MBS2320 20 mgDrug: MBS2320 40 mg
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 248
- Registration Number
- NCT05460832
- Locations
- π¨π±
Site 2102 - Clinical Research Chile SpA - PPDS, Valdivia, Chile
π§π¦Site 1201 - Univerzitetski Klinicki Centar Republike Srpske, Banja Luka, Bosnia and Herzegovina
π¨π±Site 2104 - Meditek Ltda, Santiago, Chile
Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 121
- Registration Number
- NCT03139136
- Locations
- π·π΄
Arensia, Bucharest, Romania
Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Phase 1
Completed
- Conditions
- Arthritis, Rheumatoid
- Interventions
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 105
- Registration Number
- NCT02480946
- Locations
- π¬π§
Covance Royal Liverpool Clinical Research Unit,Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom
π¬π§NIHR/Wellcome Trust Imperial Clinical Research Facility (CRF), London, United Kingdom
π¬π§Covance Clinical Research Unit Ltd., Leeds, West Yorkshire, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath